Medibank Private (MPL.AX) Osake Kurssi
Medibank Private Kurssi
Liikevaihto on kasvanut 5,8 % vuodessa viimeisten 19 vuoden aikana 9,33 Mrd. AUD:een. Osakekohtainen tulos on kasvanut 8,1 % vuodessa viimeisten 13 vuoden aikana. Medibank Privaten nettomarginaali on nyt 6,8 %, noussut 5,6 %:sta muutama vuosi sitten. Medibank Privaten osinkotuotto on tällä hetkellä noin 2,56 %. Jakosuhde on noin 129 % tuloksesta. Osinko on kasvanut 4,2 % vuodessa viimeisten 11 vuoden aikana. Analyytikoiden mediaanitavoitehinta on 5,00 AUD, eli yli nykyhintaa 7,7 %. 14 analyytikosta 5 suosittaa ostoa — kokonaiskonsensus on Pidä.
Medibank Private osakekurssi
Medibank Private liiketoimintamalli ja osakeanalyysi
Usein kysytyt kysymykset Medibank Private -osakkeesta
Medibank Private Ltd operates as a leading private health insurance provider in Australia. The company's business model revolves around offering health insurance products and services to a wide range of individuals and families. Medibank Private aims to ensure accessibility, affordability, and quality healthcare for its customers. The company's model focuses on providing comprehensive coverage, including hospital treatment, specialist consultations, and ancillary services. By leveraging its extensive network of healthcare providers and utilizing advanced technological solutions, Medibank Private delivers value-based and customer-centric healthcare solutions. With a strong emphasis on innovation and customer satisfaction, Medibank Private continues to serve as a reliable and trusted health insurance partner.
Medibank Private Ltd is primarily active in the healthcare industry.
The main competitors of Medibank Private Ltd in the market include Bupa Australia, HCF, NIB Holdings Ltd, and HBF Health Limited.
Medibank Private Ltd is an Australian private health insurance company. It was established in 1976 as a government-owned entity to provide affordable health coverage to Australians. Initially, it operated as a not-for-profit organization until it was privatized in 2014 and listed on the Australian Securities Exchange (ASX). Since then, Medibank has evolved into a leading health insurer, offering a wide range of health insurance products and services to individuals, families, and businesses across Australia. With a strong focus on customer satisfaction and innovative healthcare solutions, Medibank Private Ltd continues to play a vital role in ensuring the well-being of millions of Australians.
Medibank Private Ltd, Australia's leading health insurer, has achieved several significant milestones throughout its history. One of the key achievements was its successful initial public offering (IPO) in 2014, marking its transition from a government-owned entity to a publicly listed company. Since then, Medibank has consistently delivered strong financial performance, demonstrating its commitment to shareholder value. The company has also expanded its services by introducing innovative healthcare programs and partnerships, aimed at improving the health and well-being of its members. Medibank's focus on customer satisfaction and high-quality healthcare has enabled it to become a trusted name in the industry, further reinforcing its position as a market leader.
Medibank Private Ltd is primarily present in Australia. This leading private health insurance provider operates predominantly in its home country, catering to a wide customer base. With its headquarters located in Melbourne, Medibank Private Ltd offers a range of health insurance services and products to individuals, families, and businesses across Australia.
Medibank Private Ltd represents a commitment to delivering high-quality healthcare services to its customers. The company values customer satisfaction and aims to provide accessible and affordable healthcare for all Australians. Medibank Private Ltd places importance on innovation, investing in new technologies and approaches to improve healthcare outcomes. With a focus on corporate responsibility, the company aims to make a positive impact on the health and wellbeing of individuals and communities. Medibank Private Ltd strives to be a trusted and customer-centric healthcare provider, ensuring the utmost care and support for its customers' health needs.
Analyytikot asettavat tällä hetkellä Medibank Private-osakkeelle keskimääräisen tavoitehinnan 5,22 AUD (mediaani: 5,00 AUD), mikä merkitsee +12,4 % viimeisimpään hintaan verrattuna. Konsensus perustuu 14 analyytikkoarvioon.
14 analyytikkoa arvioi tällä hetkellä Medibank Private-osaketta: 5 suosittaa ostoa, 9 pitoa ja 0 myyntiä.
Nykyisellä valuuttakurssilla Medibank Private-osake noteerataan hintaan 2,89 EUR (4,64 AUD).
Medibank Private-osake (MPL.AX) on listattuna 5 pörssissä, muun muassa: SIX (Zürich) (MPV.SW), ASX (MPL.AX), Frankfurt (MPV.F), München (MPV.MU), Düsseldorf (MPV.DU).
Medibank Private Ltd is a leading Australian health insurance company that provides its customers with high-quality health solutions and medical services. The company operates in four main areas: health insurance, health services, private hospitals, and life insurance. It offers a wide range of health insurance products and services, including individual and family plans, group plans for businesses, and a variety of health services such as home visits, telemedicine, and emergency services. The private hospital division provides access to top-notch facilities and medical services. The company also offers life insurance products and services, including life insurance, income protection insurance, and accident insurance. Medibank Private aims to improve the customer experience through innovative technologies and digital services, offering tools and applications to manage and improve health and lifestyle. Overall, Medibank Private has a strong business model focused on providing high-quality health solutions and medical services, with a strong market position and a commitment to expanding its product and service offerings to meet the changing needs of its customers.
liikevaihto Medibank Private on 9,33 Mrd. AUD. Tämä luku perustuu nykyisiin talousarvoihin ja heijastaa yhtiön liiketoimintasuoritusta.
voitto Medibank Private on 638,70 M AUD. Nettovoitto kuvastaa yhtiön kannattavuutta kaikkien kulujen vähentämisen jälkeen.
Medibank Private:n hinta-voitto-suhde (P/E) on tällä hetkellä 20,01. P/E-suhde vertaa nykyistä osakekurssia osakekohtaiseen tulokseen ja auttaa sijoittajia arvioimaan Medibank Private-osakkeen arvostusta.
Medibank Private:n hinta-myynti-suhde (P/S) on tällä hetkellä 1,37. P/S-suhde vertaa markkina-arvoa vuosittaisiin tuloihin ja toimii Medibank Private-osakkeen arvostuskennuslukuna.
Medibank Private:n Eulpool-laatuscore on 5/10.
Medibank Private:n ISIN on AU000000MPL3. ISIN (International Securities Identification Number) on maailmanlaajuisesti ainutlaatuinen arvopaperin tunnus.
Medibank Private:n WKN on A12D1W. WKN (Wertpapierkennnummer) on kuusinumeroinen saksalainen arvopaperin tunnus.
Medibank Private:n ticker on MPL.AX. Tämä pörssinoteeraus käytetään Medibank Private-osakkeiden kauppaan pörssissä.
Medibank Private osake
Medibank Private vertaisryhmä
Medibank Private Ticker
Medibank Private FIGI
Kaikki tunnusluvut ja syvällinen analyysi Medibank Private:sta
Meidän osakeanalyysimme Medibank Private-osakkeesta sisältää tärkeitä taloudellisia tunnuslukuja, kuten liikevaihdon, voiton, P/E-luvun, P/S-luvun, EBIT:n sekä tietoja osingosta. Lisäksi tarkastelemme asioita kuten osakkeet, markkina-arvo, velat, oma pääoma ja vastuut Medibank Private:n yhteydessä. Jos etsit yksityiskohtaisempaa tietoa näistä aiheista, tarjoamme alisivuillamme kattavia analyysejä: